Skip to content

Kapelle Apotheek: what changed

BE 0501.820.986NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€40,313
2024 · €96,644-€56,331
Equity
€162,003
2024 · €121,690+€40,313
Cash
€73,807
2024 · €49,480+€24,326
Balance sheet total
€556,476
2024 · €553,843+€2,632

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€27,948

    down €27,948 (-8.6%), from €324,639 to €296,691

    of which Trade receivables: -€53,897

  • Cash +€24,326

    up €24,326 (+49.2%), from €49,480 to €73,807

    mainly Debts after one year (+€85,132) and Net result for the year (+€40,313)

  • Stocks and contracts +€8,638

    up €8,638 (+6.5%), from €133,833 to €142,471

Equity and liabilities
  • Other debts -€91,987

    down €91,987 (-79.4%), from €115,926 to €23,939

  • Debts after one year +€85,132

    new in 2025: €85,132

  • Profit (loss) carried forward +€40,313

    up €40,313 (+39.1%), from €103,090 to €143,403

  • Trade debts -€16,244

    down €16,244 (-7.6%), from €214,179 to €197,935

  • Current portion of long-term debt -€11,153

    down €11,153 (-27.9%), from €40,000 to €28,847

Income statement
  • Gross operating margin -€57,597

    down €57,597 (-14.6%), from €395,833 to €338,236

  • Taxes -€19,249

    down €19,249 (-56.6%), from €34,014 to €14,765

  • Staff costs +€15,757

    up €15,757 (+6.1%), from €256,793 to €272,549

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €96,644
Gross operating margin -€57,597
Staff costs -€15,757
Depreciation -€403
Other operating charges -€8
Financial income +€832
Financial charges -€2,647
Taxes +€19,249
Result 2025 €40,313
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€48,470
Investment -€1,183
Financing +€73,979
Cash 2024 €49,480
Net result for the year +€40,313
Depreciation +€2,661
Stocks and contracts -€8,638
Receivables within one year +€27,948
Deferred charges and accrued income +€907
Trade debts -€16,244
Tax, wage and social debts +€1,338
Advances received -€6,381
Other debts -€91,987
Accrued charges and deferred income +€1,615
Investment in fixed assets (net) -€1,183
Debts after one year +€85,132
Current portion of long-term debt -€11,153
Cash 2025 €73,807
brings cash intakes cash out
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €553,843 €556,476 +€2,632 +0.5%
Fixed assets 21/28 €12,551 €11,073 -€1,478 -11.8%
Tangible fixed assets 22/27 €12,551 €11,073 -€1,478 -11.8%
Plant, machinery and equipment 23 €850 €380 -€470 -55.3%
Other tangible fixed assets 26 €11,701 €10,693 -€1,008 -8.6%
Current assets 29/58 €541,293 €545,403 +€4,110 +0.8%
Stocks and contracts in progress 3 €133,833 €142,471 +€8,638 +6.5%
Stocks 30/36 €133,833 €142,471 +€8,638 +6.5%
Amounts receivable within one year 40/41 €324,639 €296,691 -€27,948 -8.6%
Trade receivables 40 €235,425 €181,527 -€53,897 -22.9%
Other amounts receivable 41 €89,214 €115,164 +€25,950 +29.1%
Cash at bank and in hand 54/58 €49,480 €73,807 +€24,326 +49.2%
Deferred charges and accrued income 490/1 €33,341 €32,434 -€907 -2.7%
Total equity and liabilities 10/49 €553,843 €556,476 +€2,632 +0.5%
Equity 10/15 €121,690 €162,003 +€40,313 +33.1%
Contributions 10/11 €18,600 €18,600 = 0.0%
Profit (loss) carried forward 14 €103,090 €143,403 +€40,313 +39.1%
Amounts payable 17/49 €432,153 €394,472 -€37,681 -8.7%
Amounts payable after more than one year 17 - €85,132 +€85,132
Financial debts 170/4 - €85,132 +€85,132
Amounts payable within one year 42/48 €411,925 €287,497 -€124,428 -30.2%
Current portion of amounts payable after more than one year 42 €40,000 €28,847 -€11,153 -27.9%
Trade debts 44 €214,179 €197,935 -€16,244 -7.6%
Suppliers 440/4 €214,179 €197,935 -€16,244 -7.6%
Advances received on contracts in progress 46 €6,947 €566 -€6,381 -91.9%
Taxes, remuneration and social security 45 €34,872 €36,210 +€1,338 +3.8%
Taxes 450/3 €6,419 €0 -€6,419 -100%
Remuneration and social security 454/9 €28,454 €36,210 +€7,756 +27.3%
Other amounts payable 47/48 €115,926 €23,939 -€91,987 -79.4%
Accrued charges and deferred income 492/3 €20,228 €21,843 +€1,615 +8.0%
Remuneration, social security and pensions 62 €256,793 €272,549 +€15,757 +6.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,258 €2,661 +€403 +17.9%
Other operating charges 640/8 €292 €299 +€8 +2.6%
Gross operating margin 9900 €395,833 €338,236 -€57,597 -14.6%
Operating profit (loss) 9901 €136,491 €62,726 -€73,764 -54.0%
Financial income 75/76B €3,458 €4,290 +€832 +24.0%
Recurring financial income 75 €3,458 €4,290 +€832 +24.0%
Financial charges 65/66B €9,291 €11,938 +€2,647 +28.5%
Recurring financial charges 65 €9,291 €11,938 +€2,647 +28.5%
Profit (loss) for the period before taxes 9903 €130,658 €55,078 -€75,580 -57.8%
Income taxes 67/77 €34,014 €14,765 -€19,249 -56.6%
Profit (loss) for the period 9904 €96,644 €40,313 -€56,331 -58.3%
Profit (loss) for the period to be appropriated 9905 €96,644 €40,313 -€56,331 -58.3%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€335,966 to €437,952

Midpoint €378,460 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €162,003
Capitalised earnings €509,929 to €713,900
Indication €335,966 to €437,952

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€162,003
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€162,003

Capitalised earnings

net result for the year (9904)
2025
€40,313
2024
€96,644
2023
€77,213
2022
€12,932
2021
-€27,038
excluding non-recurring income and charges
-€167
Average result
€71,390
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€509,929 / €594,917 / €713,900

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 14 November 2026 via checked.be.